Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 5
2004 4
2005 5
2006 5
2007 3
2008 8
2009 6
2010 5
2011 6
2012 4
2013 5
2014 4
2015 4
2016 8
2017 7
2018 12
2019 7
2020 12
2021 5
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG; European Intergroup for Childhood Non-Hodgkin Lymphoma; Children’s Oncology Group. Minard-Colin V, et al. N Engl J Med. 2020 Jun 4;382(23):2207-2219. doi: 10.1056/NEJMoa1915315. N Engl J Med. 2020. PMID: 32492302 Free PMC article. Clinical Trial.
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Yaniv I, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chan GCF, Ruud E, Schroeder H, Beck Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN. Ladenstein R, et al. Among authors: laureys g. Lancet Oncol. 2018 Dec;19(12):1617-1629. doi: 10.1016/S1470-2045(18)30578-3. Epub 2018 Nov 12. Lancet Oncol. 2018. PMID: 30442501 Clinical Trial.
Genes at the Crossroad of Primary Immunodeficiencies and Cancer.
Derpoorter C, Bordon V, Laureys G, Haerynck F, Lammens T. Derpoorter C, et al. Among authors: laureys g. Front Immunol. 2018 Nov 1;9:2544. doi: 10.3389/fimmu.2018.02544. eCollection 2018. Front Immunol. 2018. PMID: 30443258 Free PMC article. Review.
Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?
Garabedian L, Struyf S, Opdenakker G, Sozzani S, Van Damme J, Laureys G. Garabedian L, et al. Among authors: laureys g. Eur Cytokine Netw. 2011 Sep;22(3):148-53. doi: 10.1684/ecn.2011.0290. Eur Cytokine Netw. 2011. PMID: 22001902 Free article. Review.
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study.
Garaventa A, Poetschger U, Valteau-Couanet D, Luksch R, Castel V, Elliott M, Ash S, Chan GCF, Laureys G, Beck-Popovic M, Vettenranta K, Balwierz W, Schroeder H, Owens C, Cesen M, Papadakis V, Trahair T, Schleiermacher G, Ambros P, Sorrentino S, Pearson ADJ, Ladenstein RL. Garaventa A, et al. Among authors: laureys g. J Clin Oncol. 2021 Aug 10;39(23):2552-2563. doi: 10.1200/JCO.20.03144. Epub 2021 Jun 21. J Clin Oncol. 2021. PMID: 34152804 Clinical Trial.
Predicting outcomes for children with neuroblastoma.
Vermeulen J, De Preter K, Mestdagh P, Laureys G, Speleman F, Vandesompele J. Vermeulen J, et al. Among authors: laureys g. Discov Med. 2010 Jul;10(50):29-36. Discov Med. 2010. PMID: 20670596 Free article. Review.
The expression and role of CXC chemokines in colorectal cancer.
Verbeke H, Struyf S, Laureys G, Van Damme J. Verbeke H, et al. Among authors: laureys g. Cytokine Growth Factor Rev. 2011 Oct-Dec;22(5-6):345-58. doi: 10.1016/j.cytogfr.2011.09.002. Epub 2011 Oct 14. Cytokine Growth Factor Rev. 2011. PMID: 22000992 Review.
107 results